Myrobalan Therapeutics secures funding for CNS drug development

Myrobalan Therapeutics has secured $24m in a Series A funding round to develop CNS therapeutics with restorative potential.

Jan 11, 2024 - 18:00

Myrobalan Therapeutics secures funding for CNS drug development

Myrobalan Therapeutics has secured $24m in a Series A funding round to develop CNS therapeutics with restorative potential.

Read the original article

Tags:

Previous Article

GSK’s Nucala for severe eosinophilic asthma gains approval in China

Risk adjusted net present value: What is the current valuation of Lumos Pharma’s...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: Pharmalittle: Drugmakers agree to negotiate Medicare prices under protest; AstraZeneca settles lawsuits over heartburn drugs

STAT+: Pharmalittle: Drugmakers agree to negotiate Medi...

Oct 4, 2023

STAT+: MD Anderson tried — and failed — to resolve research credit dispute between two scientists, new documents show

STAT+: MD Anderson tried — and failed — to resolve rese...

Feb 27, 2024

Phare Bio receives ARPA-H funds for AI drug discovery platform

Phare Bio receives ARPA-H funds for AI drug discovery p...

Sep 28, 2024